Clinical Predictors of Hemorrhagic Transformation in Non Lacunar Ischemic Stroke (P6.041)

Conclusions: predictors for HT in our cohort were also related with severe vascular disease. Identification of these high risk patients is crucial in clinical decision making regarding thrombolytic treatment and optimal timing for antithrombotic therapy initiation.Disclosure: Dr. Zurru has nothing to disclose. Dr. Colla Machado has nothing to disclose. Dr. Alonzo has nothing to disclose. Dr. Brescacin has nothing to disclose. Dr. Pigretti has nothing to disclose. Dr. Luzzi has nothing to disclose. Dr. Balian has nothing to disclose. Dr. Waisman has nothing to disclose. Dr. Cristiano has received personal compensation for activities with Bayer, Biogen Idec, Merck, and Novartis.

Source: Neurology - April 3, 2016 Category: Neurology Authors: Zurru, M., Colla Machado, P., Alonzo, C., Brescacin, L., Pigretti, S., Luzzi, A., Balian, N., Waisman, G., Cristiano, E. Tags: In-Hospital Stroke and Stroke Complications Source Type: research